发明名称 Cell derived from fusion of cell 293 with cell 2B8, cell line and method for formation of human hybrid cells useful for expression of heterologous protein
摘要 <p>Human hybrid cells were made via fusion of human embryonic kidney cells (293S) and modified Burkitt's lymphoma cells (2B8). The fusion cells are useful as host cells for the recombinant expression of mammalian genes. The advantages of using these hybrid clones of human kidney- and B-cells, called HKBs, for mammalian gene expression, include (i) the cells are negative for immunoglobulin expression, (ii) the cells grow easily in plasma protein-free medium (with or without the addition of recombinant insulin) as suspension cultures in a shake flask or in a fermenter (iii) the cells are very susceptible for transfection of DNA, and (iv) the cells secrete high levels of heterologous recombinant proteins, such as recombinant monoclonal antibodies, soluble ICAM-1, rIL-4, and rFVIII.</p>
申请公布号 SK287888(B6) 申请公布日期 2012.03.02
申请号 SK20010000791 申请日期 1999.12.08
申请人 BAYER CORPORATION 发明人 CHO MYUNG-SAM
分类号 C12N5/10;C12N15/01;C07K2/00;C12N;C12N5/02;C12N5/06;C12N5/16;C12N5/22;C12N5/24;C12N15/02;C12N15/07;C12N15/08 主分类号 C12N5/10
代理机构 代理人
主权项
地址